关注
Nadia Keller
Nadia Keller
在 uq.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Type 2 interleukin-4 receptor signaling in neutrophils antagonizes their expansion and migration during infection and inflammation
J Woytschak, N Keller, C Krieg, D Impellizzieri, RW Thompson, TA Wynn, ...
Immunity 45 (1), 172-184, 2016
1342016
Clindamycin affects group a streptococcus virulence factors and improves clinical outcome
F Andreoni, C Zürcher, A Tarnutzer, K Schilcher, A Neff, N Keller, ...
The Journal of infectious diseases 215 (2), 269-277, 2017
1082017
Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection
AE Lin, FC Beasley, J Olson, N Keller, RA Shalwitz, TJ Hannan, ...
PLoS pathogens 11 (4), e1004818, 2015
862015
Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA
MR Davies, N Keller, S Brouwer, MG Jespersen, AJ Cork, AJ Hayes, ...
Nature Communications 14 (1), 1051, 2023
642023
Improved biodistribution and extended serum half-life of a bacteriophage endolysin by albumin binding domain fusion
J Seijsing, AM Sobieraj, N Keller, Y Shen, AS Zinkernagel, MJ Loessner, ...
Frontiers in microbiology 9, 2927, 2018
512018
A group A Streptococcus ADP-ribosyltransferase toxin stimulates a protective interleukin 1β-dependent macrophage immune response
AE Lin, FC Beasley, N Keller, A Hollands, R Urbano, ER Troemel, ...
MBio 6 (2), 10.1128/mbio. 00133-15, 2015
512015
Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis
DMP De Oliveira, L Bohlmann, T Conroy, FEC Jen, A Everest-Dass, ...
Science Translational Medicine 12 (570), eabb3791, 2020
442020
Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria
A Mu, WP Klare, SL Baines, CN Ignatius Pang, R Guérillot, ...
Nature Communications 14 (1), 1530, 2023
252023
Phenol soluble modulin (PSM) variants of community-associated methicillin-resistant Staphylococcus aureus (MRSA) captured using mass spectrometry-based molecular networking
DJ Gonzalez, L Vuong, IS Gonzalez, N Keller, D McGrosso, JH Hwang, ...
Molecular & Cellular Proteomics 13 (5), 1262-1272, 2014
202014
Human streptococcal necrotizing fasciitis histopathology mirrored in a murine model
N Keller, F Andreoni, C Reiber, H Luethi-Schaller, RA Schuepbach, ...
The American journal of pathology 188 (7), 1517-1523, 2018
192018
Group A Streptococcal DNase Sda1 Impairs Plasmacytoid Dendritic Cells’ Type 1 Interferon Response
N Keller, J Woytschak, LEM Heeb, EM Maggio, SM Shambat, J Snäll, ...
Journal of Investigative Dermatology 139 (6), 1284-1293, 2019
182019
Human polyspecific immunoglobulin attenuates group A streptococcal virulence factor activity and reduces disease severity in a murine necrotizing fasciitis model
A Tarnutzer, F Andreoni, N Keller, C Zürcher, A Norrby-Teglund, ...
Clinical Microbiology and Infection 25 (4), 512. e7-512. e13, 2019
182019
Interferon α–Enhanced Clearance of Group A Streptococcus Despite Neutropenia
S Uchiyama, N Keller, E Schlaepfer, C Grube, RA Schuepbach, RF Speck, ...
The Journal of infectious diseases 214 (2), 321-328, 2016
142016
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection
DMP De Oliveira, BM Forde, MD Phan, B Steiner, B Zhang, J Zuegg, ...
Mbio 13 (1), e03517-21, 2022
122022
Immunoglobulin Attenuates Streptokinase-Mediated Virulence in Streptococcus dysgalactiae Subspecies equisimilis Necrotizing Fasciitis
F Andreoni, F Ugolini, N Keller, A Neff, V Nizet, A Hollands, ...
The Journal of infectious diseases 217 (2), 270-279, 2018
92018
Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA. Nat Commun 14: 1051
MR Davies, N Keller, S Brouwer, MG Jespersen, AJ Cork, AJ Hayes, ...
72023
Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive Bacteria
DMP De Oliveira, B Keller, AJ Hayes, CLY Ong, N Harbison-Price, ...
Antibiotics 11 (4), 449, 2022
52022
Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis. Sci Transl Med 12: eabb3791
DMP De Oliveira, L Bohlmann, T Conroy, FE Jen, A Everest-Dass, ...
52020
Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1UK lineage
J Richter, AJ Cork, Y Ong, N Keller, AJ Hayes, MA Schembri, AV Jennison, ...
mBio, e03366-24, 2024
2024
Investigating group A Streptococcus antibiotic tolerance in necrotizing fasciitis
N Keller, M Boumasmoud, F Andreoni, A Tarnutzer, M von Matt, ...
Msphere 9 (9), e00634-24, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20